919 Maintenance Q8 Therapy of Crohn's Disease with Infliximab Is Associated with Endoscopic Mucosal Healing in the Long-Term
β Scribed by Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Gert A. Van Assche; Ilse Hoffman; Severine Vermeire; Paul J. Rutgeerts
- Book ID
- 119428493
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 69 KB
- Volume
- 134
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients
Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i